Reply to: "Thiazides and nonmelanoma skin cancer: Is it a class effect?"

Affiliations

¹ Department of Clinical Biochemistry and Clinical Pharmacology, Odense University Hospital, Denmark; Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense. Electronic address: sarnspang@health.sdu.dk.
² Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense.

Comment

Sidsel Arnspang Pedersen et al. J Am Acad Dermatol. 2020 Jan.

. 2020 Jan;82(1):e27.

doi: 10.1016/j.jaad.2019.09.004. Epub 2019 Sep 11.

¹ Department of Clinical Biochemistry and Clinical Pharmacology, Odense University Hospital, Denmark; Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense. Electronic address: sarnspang@health.sdu.dk.
² Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense.

No abstract available

Comment on

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA, Gaist D, Schmidt SAJ, Hölmich LR, Friis S, Pottegård A. Pedersen SA, et al. J Am Acad Dermatol. 2018 Apr;78(4):673-681.e9. doi: 10.1016/j.jaad.2017.11.042. Epub 2017 Dec 4. J Am Acad Dermatol. 2018. PMID: 29217346
Thiazides and nonmelanoma skin cancer: Is it a class effect?
Humbert X, Dolladille C, Chrétien B, Sassier M, Fedrizzi S, Puddu PE, Alexandre J. Humbert X, et al. J Am Acad Dermatol. 2020 Jan;82(1):e25-e26. doi: 10.1016/j.jaad.2019.08.086. Epub 2019 Sep 11. J Am Acad Dermatol. 2020. PMID: 31520661 No abstract available.